Alcohol plus cocaine: The whole is more than the sum of its parts

Therapeutic Drug Monitoring

Volumn 18, Issue 4, 1996, Pages 460-464

  Jatlow, Peter ^a   McCance, Elinore F ^a   Bradberry, Charles W ^a   Elsworth, John D ^a   Taylor, Jane R ^a   Roth, Robert H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaethylene; Cocaine; Dopamine; Drug abuse; Ethanol; Neurochemistry

Indexed keywords

ALCOHOL; COCAINE; HOMOCOCAINE;

ANIMAL CELL; ANIMAL TISSUE; CONFERENCE PAPER; CROSS ALLERGY; DOSE RESPONSE; DRUG POTENTIATION; ESTERIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MONOAMINE METABOLISM; NEUROCHEMISTRY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SENSITIZATION; SUBSTANCE ABUSE;

CENTRAL NERVOUS SYSTEM DEPRESSANTS; COCAINE; DOPAMINE UPTAKE INHIBITORS; ETHANOL; HUMANS; NARCOTICS; OPIOID-RELATED DISORDERS; SUBSTANCE ABUSE DETECTION;

EID: 0029812807     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199608000-00026     Document Type: Conference Paper

References (35)

1. Grant BF, Harford TC. Concurrent and simultaneous use of alcohol with cocaine: results of a national survey. Drug Alcohol Depend 1990;25:97-104.
2. Foltin RW, Fischman MW. Ethanol and cocaine interactions in humans: cardiovascular consequences. Pharmacol Biochem Behav 1989;31:877-83.
3. McCance-Katz EF, Price LH, McDougle CJ, Kosten TR, Black JE, Jatlow PI. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berlin) 1993;111: 39-46.
4. Perez-Reyes, Jeffcoat AR. Ethanol/cocaine interaction: cocaine and cocaethylene plasma concentrations and their relationship to subjective and cardiovascular effects. Life Sci 1992;51:553-63.
5. Bradberry CW, Nobiletti JB, Elsworth JD, Murphey B, Jatlow P, Roth RH. Cocaine and cocaethylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J Neurochem 1993;60:429-95.
6. Rafla FK, Epstein RL. Identification of cocaine and its metabolites in human urine in the presence of ethyl alcohol. J Anal Toxicol 1979;3:59-63.
7. Smith RM. Ethyl esters of arylhydroxy- and arylhydroxy-methoxycocaines in the urines of simultaneous cocaine and ethanol users. J Anal Toxicol 1984;8:38-42.
8. Jatlow P, Ellsworth JD, Bradberry CW, et al. Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci 1991;48: 1787-94.
9. Bailey DN. Plasma cocaethylene concentrations in patients treated in the emergency room or trauma unit. Am J Clin Pathol 1993;99:123-7.
10. Hearn WL, Flynn DD, Hime GW, et al. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem 1991;56:698-701.
11. Jatlow P. Cocaethylene: pharmacological activity and clinical significance. Ther Drug Monit 1993;15:533-6.
12. Katz JL, Terry P, Witkin JM. Comparative behavioral pharmacology and toxicology of cocaine and its ethanol-derived metabolite, cocaine ethylester (cocaethylene). Life Sci 1992;50:1351-61.
13. Woodward JJ, Mansbach R, Carroll FI, Balster RI. Cocaethylene inhibits dopamine uptake and produces cocaine-like effects in drug discrimination studies. Eur J Pharmacol 1991; 197:235-6.
14. Schechter MD. Discriminative effects of cocaethylene in rats trained to discriminate cocaine or ethanol. Life Sci 1994;55: 1033-43.
15. Kuhar MJ, Ritz MC, Boja JW. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 1990;14:299-302.
16. Xu YQ, Crumb WJ Jr, Clarkson CW. Cocaethylene, a metabolite of cocaine and ethanol, is a potent blocker of cardiac conduction channels. J Pharmacol Exp Ther 1994;271: 319-25.
17. Iyer RN, Nobiletti JB, Jatlow PI, Bradberry CN. Cocaine and cocaethylene: effects on extracellular dopamine in the primate. Psychopharmacology 1995;120:150-5.
18. Farre M, De La Torre R, Llorente M, Lamas X, Balbina U, Segura J, Cami J. Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther 1993;266:1364-73.
19. Wozniak KM, Linnoila M. Recent advances in pharmacological research on alcohol: possible relationships with cocaine. Rec Dev Alcohol 1992; 10:235-72.
20. Jacob P, Mendelson JE, Jones RT, Benowitz NL. Formation and elimination kinetics of cocaethylene in humans. Clin Pharmacol Ther 1993;53:174.
21. McCance-Katz EF, Price LH, Kosten TR, Jatlow PI. Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther 1995;274: 215-23.
22. Peres-Reyes M, Jeffcoat AR, Myers M, Sihler K, Cook CE. Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine. Psychopharmacology 1994;116:428-432.
23. McCance Katz EF, Jatlow PI. Cocaine, alcohol and cocaethylene effects in humans: Findings from a repeated dose study. College on Problems of Drug Dependence (CPDD) Annual Meeting Proceedings, 1996;162:175.
24. Dean RA, Christian CD, Sample RH, Bosron WF. Human liver esterases: ethanol mediated formation of ethylcocaine. Fed Am Soc Exp Biol 1991;5:2735-9.
25. Brzezinski MR, Abraham TL, Stone CL, Dean RA, Bosron WF. Purification and characterization of a human liver carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochem Pharmacol 1994;48:1747-55.
26. Boyer GS, Petersen DR. Enzymatic basis for the transesterification of cocaine in the presence of ethanol: evidence for the participation of microsomal carboxylesterases. J Pharmacol Exp Ther 1992;260:939-46.
27. Dean RA, Harper ET, Dumaual N, Stoecckel DA, Bosron WF. Effects of ethanol on cocaine metabolism: formation of cocaethylene and norcocaethylene. Toxicol Appl Pharmacol 1992;117:1-8.
28. Roberts SM, Harbison RD, James RC. Inhibition by ethanol of the metabolism of cocaine to benzoylecgonine and ecgonine methyl ester in mouse and human liver. Drug Metab Dispos 1993;21:537-41.
29. Roberts SM, Roth L, Harbison RD, James RC. Cocaethylene hepatotoxicity in mice. Biochem Pharmacol 1992;43: 1989-95.
30. Boelsterli UA, Wolf A, Goldin C. Oxygen free radical production mediated by cocaine and its ethanol-derived metabolite, cocaethylene, in rat hepatocytes. Hepatology 1993;18: 1154-61.
31. Hoger BA, Elsworth JD, Taylor JR, Jatlow P, Roth RH. Preexposure to cocaethylene can produce sensitization to the locomotor activating effects of cocaine. CPDD 57th Annual Meeting. National Institute on Drug Abuse research Monograph series, Rockville, MD. 1996;162:173.
32. Elsworth JD, Taylor JR, Jatlow P, Roth RH. Serotonin involvement in cocaine sensitization: clues from studies with cocaine analogs. Drug Develop Res 1993;30:189-200.
33. Pecins-Thompson M, Peris J. Behavioral and neurochemical changes caused by repeated ethanol and cocaine administration. Psychopharmacology 1993;110:443-50.
34. Elsworth JD, Medysnki MA, Jatlow P, Roth RH. Cocaethylene and other cocaine analogs: differential selectivity and potency as inhibitors of monoamine transport [Abstract]. Presented at Seventh International Catecholamine Symposium, Amsterdam, 1992.
35. Hearn WL, Rose S, Wagner J, Ciarleglio A, Mash DC. Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol Biochem Behav 1991;39:531-3.